Cargando…

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant

Host immune responses are a key source of selective pressure driving pathogen evolution. Emergence of many SARS-CoV-2 lineages has been associated with enhancements in their ability to evade population immunity resulting from both vaccination and infection. Here we show diverging trends of escape fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewnard, Joseph A., Hong, Vennis, Kim, Jeniffer S., Shaw, Sally F., Lewin, Bruno, Takhar, Harpreet, Lipsitch, Marc, Tartof, Sara Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310822/ https://www.ncbi.nlm.nih.gov/pubmed/37386005 http://dx.doi.org/10.1038/s41467-023-39567-2

Ejemplares similares

Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
por: Lewnard, Joseph A., et al.
Publicado: (2023)

Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
por: Lewnard, Joseph A, et al.
Publicado: (2023)

Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System — California, March–July 2021
por: Malden, Deborah E., et al.
Publicado: (2021)

BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
por: Tartof, Sara Y, et al.
Publicado: (2022)

BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5–11 Years of Age: A Test Negative Design
por: Tartof, Sara Y, et al.
Publicado: (2023)

Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
por: Lewnard, Joseph A, et al.
Publicado: (2021)

Effectiveness of Pneumococcal Conjugate Vaccination Against Virus-Associated Lower Respiratory Tract Infection Among Adults: A Case-Control Study
por: Lewnard, Joseph A, et al.
Publicado: (2022)

Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study
por: Bruxvoort, Katia J., et al.
Publicado: (2023)

Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years
por: Tartof, Sara Y., et al.
Publicado: (2022)

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study
por: Tartof, Sara Y, et al.
Publicado: (2022)

Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
por: Tartof, Sara Y, et al.
Publicado: (2023)

Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System
por: Tartof, Sara Y., et al.
Publicado: (2023)

Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
por: Bushman, Mary, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
por: Bruxvoort, Katia J, et al.
Publicado: (2021)

2833. Multi-drug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large U.S. integrated health care organization
por: Ku, Jennifer H, et al.
Publicado: (2023)

Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System
por: Malden, Deborah E, et al.
Publicado: (2022)

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
por: Tartof, Sara Y, et al.
Publicado: (2022)

Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study
por: Tartof, Sara Y., et al.
Publicado: (2022)

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022)

Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin
por: Al-Beltagi, Sarah, et al.
Publicado: (2021)

Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure
por: Eyal, Nir, et al.
Publicado: (2021)

906. Characteristics of Chronic Hepatitis B Patients with Severe Outcomes in a Large Integrated Healthcare System - 2008-2019
por: Florea, Ana, et al.
Publicado: (2021)

Multidrug Resistance of Escherichia coli From Outpatient Uncomplicated Urinary Tract Infections in a Large United States Integrated Healthcare Organization
por: Ku, Jennifer H, et al.
Publicado: (2023)

On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community
por: Goldstein, Edward, et al.
Publicado: (2020)

Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022)

Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data
por: Florea, Ana, et al.
Publicado: (2023)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19
por: Skarbinski, Jacek, et al.
Publicado: (2022)

1874. Prior Screening for Latent Tuberculosis among Patients Diagnosed with Active Tuberculosis: Missed Opportunities?
por: Garba, Saadiq, et al.
Publicado: (2023)

The emerging SARS-CoV-2 variants of concern
por: Sanyaolu, Adekunle, et al.
Publicado: (2021)

Emerging dominant SARS-CoV-2 variants
por: Chen, Jiahui, et al.
Publicado: (2022)

On the use of the reproduction number for SARS‐CoV‐2: Estimation, misinterpretations and relationships with other ecological measures
por: Jewell, Nicholas P., et al.
Publicado: (2022)

Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network
por: Tartof, Sara Y., et al.
Publicado: (2023)

Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants
por: Dächert, Christopher, et al.
Publicado: (2022)

Cross-reactive memory T cells and herd immunity to SARS-CoV-2
por: Lipsitch, Marc, et al.
Publicado: (2020)

Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
por: Castonguay, Nicolas, et al.
Publicado: (2021)

Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
por: Slezak, Jeff, et al.
Publicado: (2021)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Emergence of novel SARS-CoV-2 variants in the Netherlands
por: Urhan, Aysun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvrui588i36gsdnge4p2tok2g5